NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-68 Cr | ₹9.00 Cr | ₹76 Cr | ₹9.80 Cr | ₹-0.50 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NATCO PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-68 Cr |
Mar2023 | ₹9.00 Cr |
Mar2022 | ₹76 Cr |
Mar2021 | ₹9.80 Cr |
Mar2020 | ₹-0.50 Cr |
How is Net Cash Inflow / Outflow of NATCO PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-68 Cr | Negative | |
Mar2023 | ₹9.00 Cr | -88.16 | |
Mar2022 | ₹76 Cr | 675.51 | |
Mar2021 | ₹9.80 Cr | Positive | |
Mar2020 | ₹-0.50 Cr | - |
Compare Net Cash Inflow / Outflow of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,933.6 Cr | 7.3% | 7.3% | -10.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,725.0 Cr | 2.5% | 0.2% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,525.0 Cr | 2.1% | 3.7% | 66.4% | Stock Analytics | |
CIPLA | ₹123,206.0 Cr | 0.9% | 0.1% | 14.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,519.0 Cr | -0.6% | 0.4% | 28.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,927.5 Cr | -0.3% | -2.2% | -0.1% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 7.3% |
7.3% |
-10.2% |
SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses